SELENA BUONGIORNO: Open Payments
NPI 1770913543 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 44 payments from 21 companies in 2025. Trend: 2023 $162 · 2024 $700 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $241 |
| UCB, Inc. | 7 | $163 |
| Lundbeck LLC | 4 | $132 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Eisai Inc. | 4 | $81 |
| EMD Serono, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Neurelis, Inc. | 2 | $31 |
| SK Life Science, Inc. | 1 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $25 |
Products named: QULIPTA, VYEPTI, Symbravo, Leqembi, Briviact, HYQVIA, Rystiggo, UBRELVY.
Industry payments across FL — which companies pay providers there.
